Jazz Pharmaceuticals (JAZZ.MX) Q3 2024 Earnings

31JulConfirmed
Q2 2024
Q3 2024
45.47
63.23
80.99
98.75

Details

Expected EPS
91.7103124512
Actual EPS
98.75172
Surprise EPS
7.04
Surprise Percent
+7.68%

Description

Jazz Pharmaceuticals (JAZZ.MX) has reported earnings of 98.75172 per share for Q3 2024.

0 Comments

Share your thoughts